Bayesian cost-effectiveness analysis from clinical trial data

被引:71
作者
O'Hagan, A [1 ]
Stevens, JW
Montmartin, J
机构
[1] Univ Sheffield, Dept Probabil & Stat, Sheffield S3 7RH, S Yorkshire, England
[2] Astra Zeneca, Stat & Data Management Dept, Loughborough LE11 7RH, Leics, England
关键词
D O I
10.1002/sim.861
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A key tool for assessing the relative cost-effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost-effectiveness. Calculations can be performed using readily available Bayesian software. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:733 / 753
页数:21
相关论文
共 28 条
  • [1] THE CE PLANE - A GRAPHIC REPRESENTATION OF COST-EFFECTIVENESS
    BLACK, WC
    [J]. MEDICAL DECISION MAKING, 1990, 10 (03) : 212 - 214
  • [2] Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO
  • [3] 2-F
  • [4] Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO
  • [5] 2-E
  • [6] Gelman A, 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411
  • [7] Heitjan DF, 1999, HEALTH ECON, V8, P191, DOI 10.1002/(SICI)1099-1050(199905)8:3<191::AID-HEC409>3.0.CO
  • [8] 2-R
  • [9] Laska EM, 1997, HEALTH ECON, V6, P229, DOI 10.1002/(SICI)1099-1050(199705)6:3<229::AID-HEC268>3.0.CO
  • [10] 2-M